1) Percutaneous ethanol injection
经皮无水酒精注射术
1.
Objective:To analyze the effect of ultrasound-guided percutaneous ethanol injection(PEI)on immune function of patients with hepatocellular carcinoma(HCC)by monitoring the change of immune indexes in peripheral blood before and after the therapy of PEI.
目的:通过监测超声引导下经皮无水酒精注射术(PEI)治疗前、后肝细胞癌患者外周血中免疫指标的变化来分析PEI治疗对患者机体免疫功能的影响。
2) percutaneous ethanol injection
经皮穿刺无水酒精注射
1.
Objective To investigate the best adaptation of argon super cryosurgery system (ASCS) and percutaneous ethanol injection (PEI) in the treatment of small hepatocellular carcinoma (SHCC).
目的探讨氩氦刀和经皮穿刺无水酒精注射治疗治疗原发性小细胞肝癌患者的最佳适应证。
2.
Methods Percutaneous ethanol injection therapy(PEIT) were performed under the ultrasonic guidance in 42 patients with primary or secondary hepatic carcinoma.
目的探讨肝癌患者在超声引导下经皮穿刺无水酒精注射(PEI)的护理配合。
5) Percutaneous ethanol injection
经皮酒精注射
6) Percutaneous ethanol injection
无水酒精注射
1.
Objective To observe the effects of percutaneous ethanol injection therapy (PEIT) for advanced liver metastases and to explore the dose of ethanol.
方法 在CT定位和动态观察下 ,对直径 <5 0cm的肝转移癌 ,行经皮肝穿刺瘤内无水酒精注射治疗 (PEIT)。
2.
Methods 383 patients with hepatocellular carcinoma were treated with transcatheter arterial embolization(TACE),percutaneous ethanol injection(PEI),radiofrequency ablation(RF),cryosurgery treatment(CST) from December 1998 to June 2005.
方法收集本院1998-12—2005-06经肝动脉栓塞化疗(TACE)、无水酒精注射(PEI)、射频消融(RF)、氩氦刀冷冻(CST)治疗的原发性肝癌病例共383例,分别对大肝癌(直径>5 cm)和小肝癌(直径≤5 cm)4种微创疗法的近期生存率和治疗后肿块缩小率进行对比分析。
补充资料：经皮经导管腔静脉狭窄扩张与成形术
经皮经导管腔静脉狭窄扩张与成形术
介入放射学技术。经皮股静脉或颈内静脉插管，对上、下腔静脉梗阻或狭窄实施球囊成形和放置支架的技术。主要适应证为各种原因造成的上、下腔静脉狭窄和梗阻，尤其肿瘤压迫及血栓、瘤栓引起的梗阻、Budd-chiari综合征在Sugiura分型中的Ⅰ型病变。技术操作上与一般PTA操作相同，但对完全梗阻或Budd-chiari综合征可先用套管针对梗阻部位穿通后再用球囊扩张。为防止再狭窄，球囊成形术后一般需要放置支架，常用strecker、palmaz、Wallstent、Z-stent等支架。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条